Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma
Status:
NOT_YET_RECRUITING
Trial end date:
2028-09-30
Target enrollment:
Participant gender:
Summary
The protocol is a Simon's 2-stage, non-randomized, open label, multi-site, phase 2 trial for patients with advanced metastatic, recurrent and unresectable malignant melanoma that has recurred or relapsed after prior anti-PD-(L)1 therapy.